Monocytes from patients with type 1 diabetes spontaneously secrete proinflammatory cytokines inducing Th17 cells

Journal of Immunology

Volumn 183, Issue 7, 2009, Pages 4432-4439

  Bradshaw, Elizabeth M ^a   Raddassi, Khadir ^a   Elyaman, Wassim ^a   Orban, Tihamer ^b   Gottlieb, Peter A ^c   Kent, Sally C ^a   Hafler, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF COLORADO DENVER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 1BETA; INTERLEUKIN 6; INTERLEUKIN 6 ANTIBODY; AUTACOID; CYTOKINE; IL6 PROTEIN, HUMAN; INTERLEUKIN 17;

ADULT; ARTICLE; CELL ACTIVATION; CELL EXPANSION; CELL ISOLATION; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; FEMALE; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; INSULIN DEPENDENT DIABETES MELLITUS; LONG TERM CARE; MALE; MEMORY T LYMPHOCYTE; MONOCYTE; PRIORITY JOURNAL; PROTEIN INDUCTION; TH17 CELL; ADOLESCENT; BIOSYNTHESIS; BLOOD; CD4 LYMPHOCYTE COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; COCULTURE; IMMUNOLOGICAL MEMORY; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; PATHOLOGY; PHYSIOLOGY; SECRETION; TH1 CELL;

ADOLESCENT; ADULT; CD4 LYMPHOCYTE COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CHILD; COCULTURE TECHNIQUES; CYTOKINES; DIABETES MELLITUS, TYPE 1; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC MEMORY; INFLAMMATION MEDIATORS; INTERLEUKIN-17; INTERLEUKIN-1BETA; INTERLEUKIN-6; MALE; MONOCYTES; TH1 CELLS; YOUNG ADULT;

EID: 70449704670     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.0900576     Document Type: Article

References (32)

1. + effector T cells develop via a lineage distinct from the T helper type 1 and 2 lineages. Nat. Immunol. 6: 1123-1132.
2. H2 hypothesis of T cell-mediated tissue damage. Nat. Med. 13: 139-145.
3. Murphy, C. A., C. L. Langrish, Y. Chen, W. M. Blumenschein, T. K. McClanahan, R. A. Kastelein, J. D. Sedgwick, and D. J. Cua. 2003. Divergent pro- and antiinflammatory roles for IL-23 and IL-12 in joint autoimmune inflammation. J. Exp. Med. 198: 1951-1957.
4. Cua, D., J. Sherlock, Y. Chen, C. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin- 12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
5. Tzartos, J. S., M. A. Friese, M. J. Craner, J. Palace, J. Newcombe, M. M. Esiri, and L. Fugger. 2008. Interleukin-17 production in central nervous system-infiltrating T cells and glial cells is associated with active disease in multiple sclerosis. Am. J. Pathol. 172: 146-155.
6. Vukkadapu, S. S., J. M. Belli, K. Ishii, A. G. Jegga, J. J. Hutton, B. J. Aronow, and J. D. Katz. 2005. Dynamic interaction between T cell-mediated β-cell damage and γ-cell repair in the run up to autoimmune diabetes of the NOD mouse. Physiol. Genomics 14: 201-211.
7. Jain, R., D. M. Tartar, R. K. Gregg, R. D. Divekar, J. J. Bell, H. H. Lee, P. Yu, J. S. Ellis, C. M. Hoeman, C. L. Franklin, and H. Zaghouani. 2008. Innocuous IFNγ induced by adjuvant-free antigen restores normoglycemia in NOD mice through inhibition of IL-17 production. J. Exp. Med. 205: 207-218.
8. Martin-Orozco, N., Y. Chung, S. H. Chang, Y. H. Wang, and C. Dong. 2009. Th17 cells promote pancreatic inflammation but only induce diabetes efficiently in lymphopenic hosts after conversion into Th1 cells. Eur. J. Immunol. 39: 216-224.
9. Bending, D., H. De La Pena, M. Veldhoen, J. M. Phillips, C. Uyttenhove, B. Stockinger, and A. Cooke. 2009. Highly purified Th17 cells from BDC2.5NOD mice convert into Th1-like cells in NOD/SCID recipient mice. J. Clin. Invest. 119: 565-572.
10. Yang, L., D. E. Anderson, C. Baecher-Allan, W. D. Hastings, E. Bettelli, M. Oukka, V. K. Kuchroo, and D. A. Hafler. 2008. IL-21 and TGF-β are required for differentiation of human TH17 cells. Nature 454: 350-352.
11. Manel, N., D. Unutmaz, and D. R. Littman. 2008. The differentiation of human TH-17 cells requires transforming growth factor-β and induction of the nuclear receptor RORγt. Nat. Immunol. 9: 641-649. (Pubitemid 351714729)
12. Volpe, E., N. Servant, R. Zollinger, S. I. Bogiatzi, P. Hupe, E. Barillot, and V. Soumelis. 2008. A critical function for transforming growth factor-β, interleukin 23 and proinflammatory cytokines in driving and modulating human TH-17 responses. Nat. Immunol. 9: 650-657. (Pubitemid 351712635)
13. Acosta-Rodriguez, E. V., G. Napolitani, A. Lanzavecchia, and F. Sallusto. 2007. Interleukins 1β and 6 but not transforming growth factor-β are essential for the differentiation of interleukin 17-producing human T helper cells. Nat. Immunol. 8: 942-949.
14. Evans, H. G., T. Suddason, I. Jackson, L. S. Taams, and G. M. Lord. 2007. Optimal induction of T helper 17 cells in humans requires T cell receptor ligation in the context of Toll-like receptor-activated monocytes. Proc. Natl. Acad. Sci. USA 104: 17034-17039.
15. Dogan, Y., S. Akarsu, B. Ustundag, E. Yilmaz, and M. K. Gurgoze. 2006. Serum IL-1β, IL-2, and IL-6 in insulin-dependent diabetic children. Mediators Inflamm. 2006: 59206.
16. Hussain, M. J., M. Peakman, H. Gallati, S. S. S. Lo, M. Hawa, G. C. Viberti, P. J. Watkins, R. D. G. Leslie, and D. Vergani. 1996. Elevated serum levels of macrophage-derived cytokines precede and accompany the onset of IDDM. Diabetologia 39: 60-69.
17. Hussain, M. J., J. Maher, T. Warnock, A. Vats, M. Peakman, and D. Vergani. 1998. Cytokine overproduction in healthy first degree relatives of patients with IDDM. Diabetologia 41: 343-349. (Pubitemid 28254830)
18. Devaraj, S., M. R. Dasu, J. Rockwood, W. Winter, S. C. Griffen, and I. Jialal. 2008. Increased Toll-like receptor (TLR) 2 and TLR4 expression in monocytes from patients with type 1 diabetes: further evidence of a proinflammatory state. J. Clin. Endocrinol. Metab. 93: 578-583. (Pubitemid 351240834)
19. Foss-Freitas, M. C., N. T. Foss, E. A. Donadi, and M. C. Foss. 2006. In vitro TNF-α and IL-6 production by adherent peripheral blood mononuclear cells obtained from type 1 and type 2 diabetic patients evaluated according to the metabolic control. Ann. NY Acad. Sci. 1079: 177-180.
20. Giulietti, A., K. Stoffels, B. Decallonne, L. Overbergh, and C. Mathieu. 2004. Monocytic expression behavior of cytokines in diabetic patients upon inflammatory stimulation. Ann. NY Acad. Sci. 1037: 74-78. (Pubitemid 40299745)
21. Devaraj, S., N. Glaser, S. Griffen, J. Wang-Polagruto, E. Miguelino, and I. Jialal. 2006. Increased monocytic activity and biomarkers of inflammation in patients with type 1 diabetes. Diabetes 55: 774-779. (Pubitemid 43343235)
22. Padmos, R. C., N. C. Schloot, H. Beyan, C. Ruwhof, F. J. Staal, D. de Ridder, H. J. Aanstoot, W. K. Lam-Tse, H. de Wit, C. de Herder, et al. 2008. Distinct monocyte gene-expression profiles in autoimmune diabetes. Diabetes 57: 2768-2773.
23. Lahm, H. W., and S. Stein. 1985. Characterization of recombinant human interleukin- 2 with micromethods. J. Chromatogr. 326: 357-361. (Pubitemid 15069382)
24. + blood monocytes: their role in infection and inflammation. J. Leukocyte Biol. 81: 584-592.
25. + monocytes are main producers of IL-10. Scand. J. Immunol. 67: 152-159.
26. Acosta-Rodriguez, E. V., L. Rivino, J. Geginat, D. Jarrossay, M. Gattorno, A. Lanzavecchia, F. Sallusto, and G. Napolitani. 2007. Surface phenotype and antigenic specificity of human interleukin 17-producing T helper memory cells. Nat. Immunol. 8: 639-646.
27. Frigerio, S., T. Junt, B. Lu, C. Gerard, U. Zumsteg, G. A. Hollander, and L. Piali. 2002. β cells are responsible for CXCR3-mediated T-cell infiltration in insulitis. Nat. Med. 8: 1414-1420. (Pubitemid 36024137)
28. Dardalhon, V., T. Korn, V. K. Kuchroo, and A. C. Anderson. 2008. Role of Th1 and Th17 cells in organ-specific autoimmunity. J. Autoimmun. 31: 252-256.
29. + monocytes in response to sepsis-related antigens. Clin. Exp. Immunol. 141: 270-278.
30. Kaizer, E. C., C. L. Glaser, D. Chaussabel, J. Banchereau, V. Pascual, and P. C. White. 2007. Gene expression in peripheral blood mononuclear cells from children with diabetes. J. Clin. Endocrinol. Metab. 92: 3705-3711. (Pubitemid 47435359)
31. Uno, S., A. Imagawa, K. Okita, K. Sayama, M. Moriwaki, H. Iwahashi, K. Yamagata, S. Tamura, Y. Matsuzawa, T. Hanafusa, J. Miyagawa, and I. Shimomura. 2007. Macrophages and dendritic cells infiltrating islets with or without β cells produce tumour necrosis factor-α in patients with recent-onset type 1 diabetes. Diabetologia 50: 596-601.
32. Wen, L., R. E. Ley, P. Y. Volchkov, P. B. Stranges, L. Avanesyan, A. C. Stonebraker, C. Hu, F. S. Wong, G. L. Szot, J. A. Bluestone, et al. 2008. Innate immunity and intestinal microbiota in the development of type 1 diabetes. Nature 455: 1109-1113.